Boston Scientific (BSX) Price Target Cut by Jefferies on Growth Outlook

Jefferies has lowered the price target for Boston Scientific (BSX) amid concerns over its growth outlook. Specific figures on the new price target or changes in revenue estimates were not disclosed in the report. This adjustment may influence investor sentiment and trading volumes as market participants evaluate the implications for BSX. Tracking the company's performance and comparing it with sector forecasts will be essential for identifying potential market movements.